Base de données de recherche subventionnée canadienne sur la COVID-19

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 401 through 410 of 882 results (Download Results)

Show results per page

COVID-19 Variant Supplement – Development of a nanoparticle-based vaccine candidate to the SARS-CoV-2

Leclerc, Denis | CHU de Québec | Operating Grant | $50,000

CIHR Quebec 2021

Living with long-COVID. Patient experience to inform policy makers and care providers

Law, Susan K | University of Toronto | Operating Grant | $275,969

CIHR Ontario 2021

COVID-19 Variant Supplement – Improving Outcomes in Individuals with COVID‑19 with Renin-Angiotensin System Inhibition: The COVID-RASi Trial

Liu, Peter P | Ottawa Heart Institute Research Corporation | Operating Grant | $50,000

CIHR Ontario 2021

Mental Health, Substance Use, and Service Needs, Access, and Delivery among Two-Spirit, Gay, Bisexual, Queer, and Other Men Who Have Sex with Men in Manitoba

Souleymanov, Roustam | University of Manitoba | Operating Grant | $175,000

CIHR Manitoba 2020

COVID-19 Variant Supplement – Development of SARS-CoV-2 Peptide Therapeutics and Point-of-Care Salivary Diagnostics for Rapid Viral Detection

Babu, Mohan | The University of Regina | Operating Grant | $50,000

CIHR Saskatchewan 2021

Pulmonary vascular disease in patients with Long COVID

Weatherald, Jason | The University of Calgary | Operating Grant | $292,092

CIHR Alberta 2021

COVID-19 Variant Supplement – Drug repurposing for the rapid development and evaluation of SARS-CoV-2 antivirals

Côté, Marceline | University of Ottawa | Operating Grant | $50,000

CIHR Ontario 2021

Evaluating the durability and cross-reactivity of SARS-CoV-2 immunity elicited by COVID‑19 vaccines

Brockman, Mark A | Simon Fraser University | Operating Grant | $495,000

CIHR British Columbia 2021

SARS-CoV-2 triggers Autoimmunity: implications for the pathogenesis of Post-Acute COVID‑19 Syndrome – (AI-PACS)

Mukherjee, Manali | McMaster University | Operating Grant | $499,245

CIHR Ontario 2021

Evaluation of COVID‑19 antibodies, cell-mediated immunity and telomeres following COVID‑19 immunization or natural infection in an immune compromised population: An HIV Cohort Study

Gill, Michael J | The University of Calgary | Operating Grant | $434,655

CIHR Alberta 2021

Base de données de recherche subventionnée canadienne sur la COVID-19

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

COVID-19 Variant Supplement – Development of a nanoparticle-based vaccine candidate to the SARS-CoV-2

Living with long-COVID. Patient experience to inform policy makers and care providers

COVID-19 Variant Supplement – Improving Outcomes in Individuals with COVID‑19 with Renin-Angiotensin System Inhibition: The COVID-RASi Trial

Mental Health, Substance Use, and Service Needs, Access, and Delivery among Two-Spirit, Gay, Bisexual, Queer, and Other Men Who Have Sex with Men in Manitoba

COVID-19 Variant Supplement – Development of SARS-CoV-2 Peptide Therapeutics and Point-of-Care Salivary Diagnostics for Rapid Viral Detection

Pulmonary vascular disease in patients with Long COVID

COVID-19 Variant Supplement – Drug repurposing for the rapid development and evaluation of SARS-CoV-2 antivirals

Evaluating the durability and cross-reactivity of SARS-CoV-2 immunity elicited by COVID‑19 vaccines

SARS-CoV-2 triggers Autoimmunity: implications for the pathogenesis of Post-Acute COVID‑19 Syndrome – (AI-PACS)

Evaluation of COVID‑19 antibodies, cell-mediated immunity and telomeres following COVID‑19 immunization or natural infection in an immune compromised population: An HIV Cohort Study